5th Circuit Court of Appeals imposes restrictions on abortion pill mifepristone, however drug will stay on the market for now — Part Three

By Dave Andrusko At the end of the week, we’re taking still another look at this week’s  important decision by a panel of judges from the 5th U.S. Circuit Court of Appeals which “found unlawful the Biden administration’s mail-order drug regimen and held that the FDA must restore important safeguards on chemical abortion drugs,” in the words of Erin …

Continue reading "5th Circuit Court of Appeals imposes restrictions on abortion pill mifepristone, however drug will stay on the market for now — Part Three"

Another look at 5th Circuit Court of Appeals Decision that FDA’s 2016 and 2021 Changes to Mifepristone Were Unlawful

By Dave Andrusko On Wednesday a three-judge panel of the 5th Circuit Court of Appeals said “that it would restrict access to a widely used abortion medication after finding that the federal government did not follow the proper process when it loosened regulations in 2016 to make the pill more easily available,” the New York Times reported. The FDA’s “decisions …

Continue reading "Another look at 5th Circuit Court of Appeals Decision that FDA’s 2016 and 2021 Changes to Mifepristone Were Unlawful"

Fifth Circuit Court of Appeals Determines that Food and Drug Administration’s 2016 and 2021 Changes to Mifepristone Were Unlawful

Stay on Lower Court Ruling Remains While Litigation Continues WASHINGTON, D.C.— Today, a three-judge panel of the Fifth Circuit Court of Appeals, in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration (FDA), determined that when the FDA loosened regulations in 2016 and 2021 regarding the drug mifepristone, it did so unlawfully, failing to give adequate …

Continue reading "Fifth Circuit Court of Appeals Determines that Food and Drug Administration’s 2016 and 2021 Changes to Mifepristone Were Unlawful"

5th Circuit Court of Appeals imposes restrictions on abortion pill mifepristone, however drug will stay on the market for now

By Dave Andrusko A three-judge panel of the 5th Circuit Court of Appeals said Wednesday that it would impose major restrictions on the abortion pill mifepristone. The panel “said it would restrict access to a widely used abortion medication after finding that the federal government did not follow the proper process when it loosened regulations in 2016 to …

Continue reading "5th Circuit Court of Appeals imposes restrictions on abortion pill mifepristone, however drug will stay on the market for now"